Other disclosuresNSE · BALAXI
BALAXI PHARMACEUTICALS LIMITED
Press Release
01 / The disclosure
What the company shared
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated November 12, 2026, titled "Balaxi Pharmaceuticals Limited Reports Strong Q2 FY27 Performance; Revenue Grows 45%, EBITDA Surges 338% and PAT Rises 450% YoY".
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106857692
- First collected
- 12 Nov 2026, 21:07 IST
- PDF extraction
- metadata_only
You’ve reached the end of this disclosure.